As part of Temple University's ongoing efforts to respond to COVID-19 and its impact on research activities and available programs and funding for businesses. The Office of the Vice President for Research (OVPR) has issued a number of guidelines to navigate the changing environment. If you are a small business owner, OVPR has collected resources available from the state and federal government to help you keep your business afloat during the pandemic.
View the latest COVID-19-related research information and funding opportunities for the Research Community here.
View COVID-19 related available programs and funding for small businesses here.
View ongoing Research Funding opportunities here.
Notifications to Community
- July 13, 2020 Update on Human Subjects IRB Guidance Related to COVID-19
- May 23, 2020 Notice to Temple Research Community – Update on COVID-19 Return to Research Planning Process and Guidelines
- April 07, 2020 Duane Morris COVID-19 Update
- March 27, 2020 Update on Human Subjects IRB Guidance Related to COVID-19
- March 26, 2020 Office of the Vice President for Research 2020 Bridge Research Program
- March 23, 2020 NSF Dear Colleague Letter and RAPID Research on Coronavirus (COVID-19)
- March 19, 2020 Enhanced Support for COVID-19 Research Efforts
- March 16, 2020 Notice to Temple Research Community - Update on COVID-19 Research Continuity Planning
- March 16, 2020 ULAR and IACUC Communications Related to COVID-19
- March 12, 2020 Human Subjects IRB Guidance Related to COVID-19
- March 12, 2020 Research Guidance Related to COVID-19
New Opportunities for COVID-19 Research Funding
Emergent Fund (NEW-7.23.2020)
- Fast Grants- second call launched on July 12, 2020
- COVID-19 Grants- Rolling
America Diabetes Association (--Updated 5.26.2020)
Centers for Disease Control and Prevention (--Updated 6.4.2020)
- ATSDR's Partnership to Promote Local Efforts to Reduce Environmental Exposure-COVID-19 Supplement (CLOSED)
- Building Capacity for National Public Health Institutes (CLOSED)
- Global Health Security Partner Enhancement: Expanding Efforts to Improve Surveillance and Laboratory Data Interoperability (CLOSED)
- Enhancing Global Health Security: Expanding Efforts and Strategies to Protect and Improve Public Health Globally (CLOSED)
- Funding for Strengthening Global Field Epidemiology Training Program Network (CLOSED)
- Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health (CLOSED)
Department of Defense (--Updated 5.13.2020)
- BRO-20-NEWTON Newton Award for Transformative Ideas during the COVID-19 Pandemic
- Request for Information for PPE in response to COVID-19 (CLOSED)
Department of Defense Medical Technology Enterprise Consortium (--Updated 5.27.2020)
- Medical Technology Enterprise Consortium (MTEC) Wearable Diagnostic for Detection of COVID-19 Infection(CLOSED)
- Potential Request for Project Proposals (RPP) focused on the development of prototypes aimed to combat the coronavirus (COVID-19) (UPCOMING)
- MTEC-20-09-COVID-19 Treatment MIDRP Development of Treatments for COVID-19 (CLOSED)
Department of Energy
- DOE Launches National Virtual Biotechnology Laboratory (NVBL)-- NEW 5.12.2020
- DOE Resources available for COVID 19 Study (Deadline: Not announced)
Department of Health and Human Services (NEW:7.6.2020)
Biomedical Advanced Research and Developlment Authority
- BAA-18-100-SOL-00003 Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) – COVID -19—Due October 31, 2020
- Amendment 17, new AOI: 7.7.4 Diagnostic Assay for SARS-CoV-2 as part of FDA-cleared panel for influenza and other respiratory viruses using FDA-cleared platforms
- Note: Only submissions in support of COVID-19 research are being reviewed at this time. Review of all other topics is paused
- BARDA's Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement – COVID-19 Topics—Deadline Feb 03, 2023
- Biomedical Advanced Research and Development Authority (BARDA): 2019 Novel Coronavirus Medical Countermeasure Partnership Opportunities
Department of Justice (NEW-5.5.2020)
National Endowment for the Humanties (NEW-5.5.2020)
- NEH CARES: Cultural Organizations (CLOSED)
National Institutes of Health (--Updated 7.6.2020)
- Notice of Special Interest: Availability of Administrative Supplements and Revisions Supplements
- Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 9COVID-19) and the Causative Virus SARS-CoV-2
- PAR-20-237 Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01-Clinical Trial Optional)-(Deadline: December 1, 2020)
- PAR-18-781 Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed)
- NOT-GM-20-025 Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2
- NOT-TR-20-011 Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need
- NOT-AI-20-030 Notice of Special Interest (NOSI) for Research on the 2019 Novel Coronavirus (2019-nCoV) (CLOSED)
- NOT-HL-20-757 Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) (CLOSED)
National Science Foundation (--Updated 4.21.2020)
- Rapid Response Research Proposals (Revised April 3, 2020)
- RAPID Cyber Proposal
Technology Development Funding and Resources (UPDATED--6.4.2020)
- Fast-Grants: Fast Funding for COVID-19 Science (Applications are paused due to a large number of submissions. Please check here for updates)
- NSF COVID-19 Phase I SBIR/STTR Opportunity
- Science Center QED Proof-of-Concept Program
- Michelson Spark Grants COVID-19 Response Round (CLOSED-Announcement to awardees in coming weeks)
- Mozilla Open Source COVID-19-Related Technology Projects
- Amazon Web Services Diagnostic Development Initiative (DDI)
- Google Cloud Research Credits
Additional Funding Opportunities (--Updated 6.4.2020)
- John Hopkins University-COVID Decision Making Initiative (CDMI)
- Ferring Pharmaceuticals (Application window April 15th - October 31st 2020)
- Deutsche Forschungsgemeinschaft (CLOSED)
- White House Office of Science and Technology Policy (OSTP)
- Medical CBRN Defense Consortium
- C-19 Work from Home Cybersecurity Grant (CLOSED)
- 2020 AARP Community Challenge (CLOSED)
Resources
- COGR: Institutitonal and Agency Responses to COVID-19 and Additional Resources (NEW 5.12.2020)
- IRB Guidance on Human Subjects Protections Considerations Related to COVID-19
- IACUC Guidance on Animal Care Related to COVID-19
Sponsor Guidance Related to COVID-19
Office of Management and Budget (Updated-- 7.23.2020)
- M-20-26, "Extension of Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations"
- M-20-17, “Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations”
- M-20-11, "Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly impacted by the Novel Coronavirus (COVID-19)"
Defense Advanced Research Projects Agency
National Institutes of Health
- NIH Message to Applicants and Recipients of NIH Funds on Flexibilities Needed for COVID-19
- Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19
- Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients
- Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19
- FAQs on COVID-19 Flexibilities for Applicants and Recipients
- NIH LATE APPLICATION POLICY Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19)
- General Frequently Asked Questions (FAQs) - Proposal Submission and Award Management Related to COVID-19
- NIH Guidance on Travel and Meetings Hosted by NIH
- NIH Extramural Response to Natural Disasters and Other Emergencies
- Special OLAW Webinar on March 19: Pandemic Contingency Planning and Its Impact on Animal Care
Department of Defense
Department of Energy
- FAQ's for DOD Research Proposers and Awardees Impacted by the Novel Coronavirus (COVID-19)
- March 2020 Memorandum; Accommodating Interruptions from Coronavirus Disease 2019
National Aeronautics and Space Administration : Assistant Administrator for Procurement Message on Coronavirus
National Science Foundation
- Proposal & Award Policies & Procedures Guide (NEW-4.2.2020)
- Additional Guidance on NSF's Implementation
- Impact on Existing Deadline Dates
U.S. Food and Drug Administration : Guidance on Clinical Trials